Wednesday, 24 May 2017

Association of delayed adjuvant chemotherapy with survival after lung cancer surgery

A recent retrospective study of 12 473 patients with NSCLC from the National Cancer Database found that, adjuvant chemotherapy given later (57–127 days) in the postoperative period was not associated with mortality. Furthermore, patients who received adjuvant chemotherapy later had a significantly better survival when compared with patients treated with surgery alone.

Read more here.

No comments:

Post a Comment